JANA Partners Discloses New 5.5% Stake In Immucor (BLUD)
More News related to BLUD
- The Pomerantz Firm Charges Immucor, Inc. With Securities Fraud -- BLUD
- After-Hours Movers 10/01: TELK, ONCY, QLTI, BLUD, FSLR Higher; GRT, RECN, SMOD, ACN, NCT, KEG Lower
- Immucor (BLUD) Tops Q1 EPS by 5c; Reaffirms Forecast
- Immucor Announces Fiscal First Quarter Results
- Trading Radar for 10/1: Constellation Brands (STZ), Accenture (ACN), Global Payment (GPN) Report; Personal Income/Spending, Jobless Claims, Pending Home Sales, Auto/Truck Sales Due
In a 13G filing on Immucor Inc. (Nasdaq: BLUD), hedge fund JANA Partners disclosed a 5.5% stake, or 3,865,413 shares, in the company. The firm did not show a stake in BLUD at the quarter ended March 31, 2009. A 13G indicates a 'passive investment' above 5%.
Immucor, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of various reagents and automated systems. Its products are used primarily by hospitals, clinical laboratories, and blood banks.
Related Categories
13GsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
